Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 4Phase 3 3Phase 4 2Phase 1 2Phase 1/2 1

Status

Unknown 2Withdrawn 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Hepatocellular 4

Interventions

Exercise 440Blood Specimen Collection 334Standard of Care 325Magnetic Resonance Spectroscopy 259Radiotherapy 255Surveys and Questionnaires 246Radiosurgery 245Methods 231Educational Status 231Early Intervention, Educational 219Interviews as Topic 149Practice Guidelines as Topic 147Biopsy 145Surgical Procedures, Operative 135Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 111Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 96Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 82Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Interventional × Chemoembolization, Therapeutic × Clear all
NCT04231929 2022-03-28

BIOPEARL-FIRST

Terumo Europe N.V.

Phase NA Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

NCT02548780 2020-01-27

LifePearl-Doxo Pharmacokinetic (PK) Study

Terumo Europe N.V.

Phase NA Completed
15 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01393093 2017-06-12

TACE-KMG

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
2,840 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01393197 2015-12-18

TACE-KMG

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
2,480 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡